ProjectVALIdation of a Treatment Decision Pathway for Andexanet Alfa- VALIDA -
Basic data
Title:
VALIdation of a Treatment Decision Pathway for Andexanet Alfa- VALIDA -
Duration:
01/10/2024 to 31/10/2026
Abstract / short description:
VALIdation of a Treatment Decision Pathway for Andexanet Alfa
- VALIDA -
- VALIDA -
Involved staff
Managers
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Neurology with Focus on Neurovascular Diseases
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Dresden, Sachsen, Germany